Sanofi ADR
NASDAQ: SNY
$47.95
Real Time Data Delayed 15 Min.
SNY Stock Chart and Intraday Price
SNY Stock Data
Asset Type | Common Stock |
Exchange | NASDAQ |
Currency | USD |
Country | USA |
Sector | LIFE SCIENCES |
Industry | PHARMACEUTICAL PREPARATIONS |
Address | 54 RUE LA BOETIE, PARIS, FR |
Fiscal Year End | December |
Latest Quarter | 2023-12-31 |
Market Cap | 123,666.10M USD |
Shares Outstanding | 2,496,450,000 |
SNY Articles
Investors have been running on a high for the last several months as all major U.S. indices have reached new record levels seemingly month after month. Sentiment on the stock market has never been...
Published:
It was nice while it lasted, and it may not be over, but the AI-driven stock market rally may run out of gas fast. While the Magnificent 7 has soared (the group of big tech companies that have driven...
Published:
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third quarter running. Many top...
Published:
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
Published:
While many Wall Street firms are suggesting short Treasury paper and money markets now, for long-term investors looking for growth and income, healthcare is the place to be for the rest of 2023 and...
Published:
Here are six European Dividend Aristocrats that are the most liquid and well-known for U.S. investors who are looking for income and a degree of diversification away from the American indexes.
Published:
For growth and income investors, adding top-quality dividend stocks based in Europe to domestic portfolios may be a solid way to go for the rest of the year. These five top European stocks are liquid...
Published:
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
Published:
In what could be a long and brutal bear market in the United States, it may make sense for investors to look to Europe for some ideas now. These five top European stocks have liquidity and all pay...
Published:
Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of the best entry points in months. The stocks also are rated Buy at top...
Published:
24/7 Wall St. screened the top European Dividend Aristocrats looking for the most liquid and well-known names for investors seeking income and a degree of diversification away from the American...
Published:
Wednesday morning's biggest movers weren't meme stocks but the more usual biotechs with good news, IPOs with a bang and a big-premium acquisition. There are some meme movers as well though.
Published:
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
Published:
Principia Biopharma shares jumped to start out the week after it was announced that it would be acquired by Sanofi.
Published:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published: